Literature DB >> 18063928

Normalization of the increased translocation of endotoxin from gram negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome.

Michael Maes1, Francis Coucke, Jean-Claude Leunis.   

Abstract

There is now evidence that chronic fatigue syndrome (CFS) is accompanied by an increased translocation of endotoxins from gram-negative enterobacteria through the gut wall, as demonstrated by increased prevalences and median values for serum IgM and IgA against the endotoxins of gram-negative enterobacteria. This condition can also be described as increased gut permeability or leaky gut and indicates intestinal mucosal dysfunction (IMD). Here we report a case of a 13 year old girl with CFS who showed very high values for serum IgM against the LPS of some enterobacteria and signs of oxidative and nitrosative stress, activation of the inflammatory response system, and IgG3 subclass deficiency. Upon treatment with specific antioxidants and a "leaky gut diet", which both aim to treat increased gut permeability, and immunoglobins intravenously, the increased translocation of the LPS of gram negative enterobacteria normalized and this normalization was accompanied by a complete remission of the CFS symptoms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063928

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  21 in total

Review 1.  Biomarkers for chronic fatigue.

Authors:  Nancy G Klimas; Gordon Broderick; Mary Ann Fletcher
Journal:  Brain Behav Immun       Date:  2012-06-23       Impact factor: 7.217

2.  A Comparison of Immune Functionality in Viral versus Non-Viral CFS Subtypes.

Authors:  Nicole Porter; Athena Lerch; Leonard A Jason; Matthew Sorenson; Mary Ann Fletcher; Joshua Herrington
Journal:  J Behav Neurosci Res       Date:  2010-06-01

Review 3.  Environmental Exposures and Neuropsychiatric Disorders: What Role Does the Gut-Immune-Brain Axis Play?

Authors:  Shannon Delaney; Mady Hornig
Journal:  Curr Environ Health Rep       Date:  2018-03

Review 4.  Zinc and gastrointestinal disease.

Authors:  Sonja Skrovanek; Katherine DiGuilio; Robert Bailey; William Huntington; Ryan Urbas; Barani Mayilvaganan; Giancarlo Mercogliano; James M Mullin
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

5.  Increased Root Canal Endotoxin Levels are Associated with Chronic Apical Periodontitis, Increased Oxidative and Nitrosative Stress, Major Depression, Severity of Depression, and a Lowered Quality of Life.

Authors:  Cinthya Gomes; Frederico Canato Martinho; Décio Sabbatini Barbosa; Leonardo Santos Antunes; Helvécio Cardoso Corrêa Póvoa; Thiago Hissnauer Leal Baltus; Nayara Rampazzo Morelli; Heber Odebrecht Vargas; Sandra Odebrecht Vargas Nunes; George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

6.  Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2013-09-10       Impact factor: 3.584

Review 7.  Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways.

Authors:  Michael Maes; Frank N M Twisk
Journal:  BMC Med       Date:  2010-06-15       Impact factor: 8.775

8.  Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Authors:  Sanjay K Shukla; Dane Cook; Jacob Meyer; Suzanne D Vernon; Thao Le; Derek Clevidence; Charles E Robertson; Steven J Schrodi; Steven Yale; Daniel N Frank
Journal:  PLoS One       Date:  2015-12-18       Impact factor: 3.240

9.  Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress.

Authors:  Iciar Gárate; Borja García-Bueno; José Luis Muñoz Madrigal; Javier R Caso; Luis Alou; María Luisa Gómez-Lus; Juan Carlos Leza
Journal:  J Neuroinflammation       Date:  2014-01-11       Impact factor: 8.322

10.  The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II.

Authors:  Aristo Vojdani; Jama Lambert
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-16       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.